Next Article in Journal
Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study
Next Article in Special Issue
The Comparative Value of Serum Angiotensin Converting Enzyme (ACE) and Lysozyme and the Use of Polyclonal Antibody Activation in the Work-up of Ocular Sarcoidosis
Previous Article in Journal
COVID-19 Impact on Diagnostic Innovations: Emerging Trends and Implications
Open AccessReview

Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives

1
COVID-19 Medicine Unit and Geriatrics Clinic, “SS Annunziata” Hospital of Chieti, 66100 Chieti, Italy
2
Department of Neuroscience, Imaging and Clinical Sciences, Institute of Radiology, “SS. Annunziata” Hospital, “G. D’Annunzio” University, 66100 Chieti, Italy
3
COVID-19 Medicine Unit and Medical Clinic, “SS Annunziata” Hospital of Chieti, Department of Medicine and Science of Aging, “G D’Annunzio” University of Chieti, 66100 Chieti, Italy
4
COVID-19 Medicine Unit and Geriatrics Clinic, “SS Annunziata” Hospital of Chieti, Department of Medicine and Science of Aging and CAST, “G D’Annunzio” University of Chieti, 66100 Chieti, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Philippe A. Grenier
Diagnostics 2021, 11(2), 183; https://doi.org/10.3390/diagnostics11020183
Received: 15 December 2020 / Revised: 14 January 2021 / Accepted: 21 January 2021 / Published: 27 January 2021
(This article belongs to the Special Issue Diagnosis and Management of Sarcoidosis)
The recent COVID-19 pandemic has dramatically changed the world in the last months, leading to a serious global emergency related to a novel coronavirus infection that affects both sexes of all ages ubiquitously. Advanced age, cardiovascular comorbidity, and viral load have been hypothesized as some of the risk factors for severity, but their role in patients affected with other diseases, in particular immune disorders, such as sarcoidosis, and the specific interaction between these two diseases remains unclear. The two conditions might share similar imaging findings but have distinctive features that are here described. The recent development of complex imaging softwares, called deep learning techniques, opens new scenarios for the diagnosis and management. View Full-Text
Keywords: sarcoidosis; SARS-CoV-2 infection; COVID-19; computed tomography; ultrasound; lung; pneumonia sarcoidosis; SARS-CoV-2 infection; COVID-19; computed tomography; ultrasound; lung; pneumonia
Show Figures

Figure 1

MDPI and ACS Style

Tana, C.; Mantini, C.; Cipollone, F.; Giamberardino, M.A. Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives. Diagnostics 2021, 11, 183. https://doi.org/10.3390/diagnostics11020183

AMA Style

Tana C, Mantini C, Cipollone F, Giamberardino MA. Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives. Diagnostics. 2021; 11(2):183. https://doi.org/10.3390/diagnostics11020183

Chicago/Turabian Style

Tana, Claudio; Mantini, Cesare; Cipollone, Francesco; Giamberardino, Maria A. 2021. "Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives" Diagnostics 11, no. 2: 183. https://doi.org/10.3390/diagnostics11020183

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop